D09.22

Clinical Causes: Chronic exposure to sunlight or ultraviolet (UV) rays Genetic predispositions or family history of eye cancers History of skin or mucous membrane cancers Immune system suppression or compromised immunity Certain environmental and occupational exposures to carcinogens Pre-existing eye conditions or injuries that cause persistent irritation

Key Symptoms: Unnoticed or mild vision disturbances in the affected eye Presence of cloudy or irregular spots on the surface of the eye Possible redness or inflammation Sensation of a foreign body or irritation in the eye In rare cases, visible changes or growths on the eye surface No symptoms in early stages, making regular eye examinations important

Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an eye care professional. Procedures may include slit-lamp microscopy to inspect the eye surface closely, ocular surface biopsy in which a small tissue sample is taken for microscopic analysis, and imaging tests like high-resolution ocular coherence tomography (OCT) to assess the extent of cellular changes. The goal is to confirm whether atypical cells are confined to the surface and to rule out invasive cancer or other eye conditions.

Treatment Protocols: Treatment strategies largely focus on removing the abnormal cells while preserving vision and eye health. Common approaches include: - Topical chemotherapeutic agents like mitomycin C to target abnormal cells - Cryotherapy (freezing treatment) to destroy surface lesions - Laser therapy, such as argon laser, to ablate abnormal tissues - Surgical excision using specialized techniques to remove the affected tissue - Close follow-up examinations to monitor for recurrence or progression Early intervention often results in more straightforward treatment and a better prognosis, emphasizing the importance of timely detection.